# Marker Assisted Selective ThErapy in Rare Cancers: Knowledge Database Establishing registrY Asia

> **NCT05217407** · — · RECRUITING · sponsor: **National Cancer Center, Japan** · enrollment: 1000 (estimated)

## Conditions studied

- Rare Malignant Neoplasm

## Interventions

- **OTHER:** Genomic sequence

## Key facts

- **NCT ID:** NCT05217407
- **Lead sponsor:** National Cancer Center, Japan
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-11-30
- **Primary completion:** 2027-03-31
- **Final completion:** 2030-03-31
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2024-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05217407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05217407, "Marker Assisted Selective ThErapy in Rare Cancers: Knowledge Database Establishing registrY Asia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05217407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*